D. Overbosch

发表

Anti-Malaria Drug Mefloquine Induces Motor Learning Deficits in Humans

C. I. Zeeuw, S. Koekkoek, T. V. van Essen, 2010, Front. Neurosci..

Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey.

R. López-Vélez, D. Overbosch, P. van Damme, 2004, Journal of travel medicine.

Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria.

P. V. van Genderen, D. Overbosch, I. M. van der Meer, 2006, Journal of travel medicine.

Serodiagnosis of Imported Schistosomiasis by a Combination of a Commercial Indirect Hemagglutination Test with Schistosoma mansoni Adult Worm Antigens and an Enzyme-Linked Immunosorbent Assay with S. mansoni Egg Antigens

D. Overbosch, T. van Gool, M. Doenhoff, 2002, Journal of Clinical Microbiology.

Prognostic significance of plasma lactate levels on admission in non-immune travellers with various species of imported malaria

D. Overbosch, D. Hesselink, P. Petit, 2006 .

Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin.

D. Overbosch, R. van Furth, H. Mattie, 1985, British journal of clinical pharmacology.

Complete and partial deficiencies of complement factor D in a Dutch family.

D. Overbosch, M. Daha, P. Hiemstra, 1989, The Journal of clinical investigation.

Renal Clearance of Temocillin in Volunteers

D. Overbosch, H. Mattie, C. Gulpen, 2012, Drugs.

Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

D. Overbosch, K. Kain, J. Knobloch, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Protracted fever after a journey to India and Nepal: a case of persistent Salmonella paratyphi infection.

P. V. van Genderen, D. Overbosch, P. Petit, 2006, Journal of travel medicine.

“Trots and Runs’: Diarrhoea in Travellers to the Tropics

D. Overbosch, V. Panday, 1989 .

Targeting of blood safety measures to affected areas with ongoing local transmission of malaria

D. Overbosch, H. Zeller, W. Van Bortel, 2016, Transfusion medicine.

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study

D. Overbosch, K. Kain, J. Chulay, 2000, The Lancet.

'The tropics in our bathroom': chronic diarrhoea after return from the tropics.

D. Overbosch, M. Ledeboer, 1995, Scandinavian journal of gastroenterology. Supplement.

East and west, home is best? A questionnaire-based survey on mortality of Dutch travelers abroad.

P. V. van Genderen, D. Overbosch, A. Groenheide, 2011, Journal of travel medicine.

The quality of travel clinics in the Netherlands.

D. Overbosch, G. Sonder, A. van den Hoek, 2006, Journal of travel medicine.

The effect of probenecid on the renal tubular excretion of benzylpenicillin.

D. Overbosch, H. Mattie, D Overbosch, 1988, British journal of clinical pharmacology.

The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.

D. Overbosch, P. van Damme, R. Steffen, 2007, Journal of travel medicine.

Parasitic rheumatism presenting as oligoarthritis. A case report.

D. Overbosch, J. Macfarlane, J. D. de Jonge-Bok, 1985, Tropical and geographical medicine.

Trends in the knowledge, attitudes and practices of travel risk groups towards prevention of malaria: results from the Dutch Schiphol Airport Survey 2002 to 2009

P. V. van Genderen, D. Overbosch, P. Mulder, 2012, Malaria Journal.

Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years.

D. Overbosch, F. Peyron, F. Weber, 2006, Journal of travel medicine.

Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.

B. Stricker, D. Overbosch, B. Stricker, 2004, British journal of clinical pharmacology.

The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].

P. V. van Genderen, D. Overbosch, Kimberly Spong, 2007, Journal of travel medicine.

Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy.

D. Overbosch, 1992, Schweizerische medizinische Wochenschrift.

Hepatic amoebiasis. Current concepts and a report of 25 cases in the Netherlands.

D. Overbosch, H. J. van der Kaay, P. Stuiver, 1983, Acta Leidensia.

Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis

D. Overbosch, H. Mattie, A. Polderman, 2004, European Journal of Clinical Pharmacology.

Trends in knowledge, attitudes, and practices of travel risk groups toward prevention of hepatitis A: results from the Dutch Schiphol Airport survey 2002 to 2009.

P. V. van Genderen, D. Overbosch, P. Mulder, 2012, Journal of travel medicine.

[Increase of malaria in the Dominican Republic].

D. Overbosch, H. Schilthuis, 2000, Nederlands tijdschrift voor geneeskunde.

Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10‐year single‐center experience with a standardized treatment protocol

David Overbosch, P. V. van Genderen, D. Overbosch, 2010, Transfusion.

MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine

B. Stricker, J. Dieleman, M. Molokhia, 2006, Clinical pharmacology and therapeutics.

Trends in the knowledge, attitudes and practices of travel risk groups toward prevention of hepatitis B: results from the repeated cross-sectional Dutch Schiphol Airport Survey 2002-2009.

P. V. van Genderen, D. Overbosch, P. Mulder, 2014, Travel medicine and infectious disease.

P. V. van Genderen, D. Overbosch, G. Driessen, 2012, Journal of travel medicine.

Pharmacoepidemiology and Prescription Neuropsychiatric Events during Prophylactic Use of Mefloquine before Travelling

B. Stricker, D. Overbosch, J. Tulen, 2022 .

Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events *

B. Stricker, D. Overbosch, R. Ligthelm, 2002, Clinical pharmacology and therapeutics.

The knowledge, attitudes and practices of wintersun vacationers to the Gambia toward prevention of malaria: is it really that bad?

P. V. van Genderen, D. Overbosch, P. Mulder, 2014, Malaria Journal.

Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.

D. Overbosch, 2006, Journal of travel medicine.

Carcinoma of the colon presenting as Streptococcus sanguis bacteremia.

D. Overbosch, C. Siegert, 1995, The American journal of gastroenterology.

[First case of chikungunya diagnosed in the Netherlands].

D. Overbosch, G. V. van Doornum, M. Heijstek, 2008, Nederlands tijdschrift voor geneeskunde.

Keeping venomous snakes in the Netherlands: a harmless hobby or a public health threat?

P. V. van Genderen, D. Overbosch, L. Slobbe, 2013, The Netherlands journal of medicine.

Travel health preparation and travel-related morbidity of splenectomised individuals.

P. V. van Genderen, D. Overbosch, W. de Graaf, 2012, Travel medicine and infectious disease.